The first five-year cumulative revenue (2017–2021) global allergy diagnostics market is projected to reach US$ 5,417.6 Mn, as compared to a significantly higher cumulative revenue total of the latter five years of the forecast period (2022–2026). The inhaled allergen segment in the global allergy diagnostics market is estimated to account for the major revenue share of 48.3% in 2017.
Among the product type segments, assay kits segment is projected to account comparatively higher share in the global allergy diagnostics market owing to simplified procedure and result insurance. Among the allergen type segments, inhaled allergens segment is expected to account for majority revenue share contribution to the global allergy diagnostics market during the forecast period.
Companies profiled in the report are BioMerieux SA, Danaher Corporation, Hitachi Chemical Diagnostics Inc. Siemens AG, Thermo Fisher Scientific Inc., Stallergenes Greer, HOB Biotech Group Co. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc.